Quantcast

World Infectious Disease Testing Market Prospects Discussed in New VPG Report Available at MarketPublishers.сom

September 5, 2012

New research report “Future Horizons in the Global Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Country” prepared by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

London, UK (PRWEB) September 04, 2012

Among the key drivers of the microbiology testing market one can name the ongoing spread of AIDS, which remains the world´s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and wider availability of immunosuppressive drugs.

Though for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

New research report “Future Horizons in the Global Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Country” prepared by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Future Horizons in the Global Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Country

Published: August, 2012

Pages: 1900

Price: US$ 28,700.00 http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/future-horizons-in-global-infectious-disease-testing-market-supplier-shares-n-sales-forecasts-4-100-tests-by-country.html

The market research report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

The study provides market segmentation analysis of over 90 diseases and viruses in the seven countries such as France, Germany, Italy, Japan, Spain, the UK and the USA; assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of the leading suppliers and recent market entrants with innovative technologies and products.

Report Contents:

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

1. AIDS

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. Adeno-Associated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Arboviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Babesiosis

a. Background

7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

8. Blastocystis Hominis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

9. Brucella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

10. Campylobacter

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

11. Candida

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

12. Chagas Disease

a. Background

13. Chancroid

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

14. Chlamydia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

b. Diagnostic Tests

c. Drugs and Vaccines

More new reports by the publisher can be found at VPG page.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9865959.htm


Source: prweb



comments powered by Disqus